Login / Register
MS Validated Antibodies GmbH
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
  • Publications
    • Large Scale Studies
    • Further Publications
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
  • Publications
    • Large Scale Studies
    • Further Publications
  • Contact
×

Cancer Tissue Gallery Synaptophysin

Path Created with Sketch.
Go to Synaptophysin Normal Tissue GalleryGo back to Product Page
Adrenal gland – Adrenocortical adenoma with a weak to moderate , mostly membranous Synaptophysin immunostaining in about 50% of tumor cells.
Adrenal gland - Adrenocortical adenoma with a weak to moderate , mostly membranous Synaptophysin immunostaining in about 50% of tumor cells.
Adrenal gland – Adrenocortical adenoma with a weak Synaptophysin immunostaining in few tumor cells.
Adrenal gland - Adrenocortical adenoma with a weak Synaptophysin immunostaining in few tumor cells.
Adrenal gland – Moderate to strong Synaptophysin positivity in an adrenocortical adenoma.
Adrenal gland - Moderate to strong Synaptophysin positivity in an adrenocortical adenoma.
Adrenal gland – Pheochromocytoma with strong, diffuse Synaptophysin positivity in all tumor cells.
Adrenal gland - Pheochromocytoma with strong, diffuse Synaptophysin positivity in all tumor cells.
Breast – Invasive breast cancer of no special type (NST) exhibiting a weak to moderate Synaptophysin immunostaining of all tumor cells.
Breast - Invasive breast cancer of no special type (NST) exhibiting a weak to moderate Synaptophysin immunostaining of all tumor cells.
Breast – Synaptophysin negative invasive breast cancer of no special type (NST).
Breast - Synaptophysin negative invasive breast cancer of no special type (NST).
Lung – Small cell carcinoma showing a moderate Synaptophysin immunostaining of all tumor cells.
Lung - Small cell carcinoma showing a moderate Synaptophysin immunostaining of all tumor cells.
Lung – Synaptophysin negative adenocarcinoma.
Lung - Synaptophysin negative adenocarcinoma.
Pancreas – Neuroendocrine tumor exhibiting strong cytoplasmic Synaptophysin immunostaining of tumor cells.
Pancreas - Neuroendocrine tumor exhibiting strong cytoplasmic Synaptophysin immunostaining of tumor cells.
Prostate – Synaptophysin negative adenocarcinoma (Gleason 3+3=6).
Prostate - Synaptophysin negative adenocarcinoma (Gleason 3+3=6).
Prostate – Synaptophysin positive adenocarcinoma (Gleason 5+5=10).
Prostate - Synaptophysin positive adenocarcinoma (Gleason 5+5=10).
Retroperitoneum – Diffuse, moderate to strong Synaptophysin immunostaining of all cells of a leiomyosarcoma.
Retroperitoneum - Diffuse, moderate to strong Synaptophysin immunostaining of all cells of a leiomyosarcoma.
Skin – Merkel cell carcinoma displaying an intense cytoplasmic Synaptophysin immunostaining of all tumor cells.
Skin - Merkel cell carcinoma displaying an intense cytoplasmic Synaptophysin immunostaining of all tumor cells.
Skin – Synaptophysin negative basal cell carcinoma.
Skin - Synaptophysin negative basal cell carcinoma.
Stomach – Synaptophysin negative adenocarcinoma (intestinal type).
Stomach - Synaptophysin negative adenocarcinoma (intestinal type).
Thyroid – Medullary carcinoma with strong cytoplasmic synaptophysin immunostaining of all tumor cells.
Thyroid - Medullary carcinoma with strong cytoplasmic Synaptophysin immunostaining of all tumor cells.
Urinary bladder – Small cell carcinoma with diffuse, intense cytoplasmic Synaptophysin positivity.
Urinary bladder - Small cell carcinoma with diffuse, intense cytoplasmic Synaptophysin positivity.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2023 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors